GENE GERMANO: Open Payments
NPI 1881870442 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 51 payments from 11 companies in 2025. Trend: 2023 $193 · 2024 $750 · 2025 $1,567
Food & beverage: $1,367Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $588 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $220 |
| Janssen Pharmaceuticals, Inc | 4 | $203 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| Braeburn Inc. | 3 | $66 |
| Gilead Sciences, Inc. | 2 | $49 |
| Alkermes, Inc. | 1 | $26 |
| TMS NeuroHealth Centers Inc. | 1 | $23 |
Products named: VRAYLAR, SPRAVATO, CAPLYTA, JOURNAVX, COBENFY, BRIXADI, INVEGA SUSTENNA, ARISTADA.
Industry payments across VA — which companies pay providers there.
